New Ultra-Rugged Device Designed Tough for Military and Air Medical Operations  

July 30, 2010?CHELMSFORD, MASS.–ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin distribution of the new Propaq^® MD Monitor/Defibrillator that was developed specifically to meet the special needs of military customers and air medical operations worldwide.  Development of this product was a joint undertaking between the Department of Defense and a cooperative arrangement between Welch Allyn and ZOLL.  Development was facilitated with grants from the U.S. Army Medical Research and Development Command.

The Propaq MD is a new ultra-lightweight compact device with highly sophisticated, advanced capabilities that combine the well-accepted and proven features of the Propaq monitors with the clinically superior therapeutic capabilities of ZOLL defibrillation and non-invasive pacing technologies.  The Propaq MD is 60 percent smaller and 40 percent lighter than other similar monitor/defibrillators.  It is two pounds lighter than the current military vital signs monitor, the Propaq 206, even with defibrillation and pacing added.